Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone Versus Ketorolac for Shoulder Impingement
NCT03913702Phase 2Terminated
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Sep 2019
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketorolac in shoulder impingement syndrome (SIS), sponsored by The University of Texas Medical Branch at Galveston. Started Sep 2019; status: terminated.
02
Drugs
ketorolac
03
Conditions
shoulder impingement syndrome (SIS)
Beyond the preview
Go deeper on NCT03913702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03913702.